Boston Partners Has $109.89 Million Position in Keurig Dr Pepper, Inc (NASDAQ:KDP)

Boston Partners increased its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP) by 29.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,210,595 shares of the company’s stock after acquiring an additional 736,567 shares during the quarter. Boston Partners’ holdings in Keurig Dr Pepper were worth $109,893,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. ST Germain D J Co. Inc. acquired a new position in Keurig Dr Pepper in the 1st quarter valued at $27,000. Continuum Advisory LLC grew its holdings in Keurig Dr Pepper by 82.5% in the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company’s stock valued at $46,000 after buying an additional 602 shares in the last quarter. Global Trust Asset Management LLC acquired a new position in Keurig Dr Pepper in the 1st quarter valued at $48,000. LRI Investments LLC grew its holdings in Keurig Dr Pepper by 65.6% in the 4th quarter. LRI Investments LLC now owns 1,527 shares of the company’s stock valued at $49,000 after buying an additional 605 shares in the last quarter. Finally, Riverview Trust Co grew its holdings in Keurig Dr Pepper by 47.7% in the 1st quarter. Riverview Trust Co now owns 1,710 shares of the company’s stock valued at $59,000 after buying an additional 552 shares in the last quarter. 93.99% of the stock is owned by institutional investors and hedge funds.

Keurig Dr Pepper Stock Performance

NASDAQ:KDP opened at $34.82 on Thursday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. Keurig Dr Pepper, Inc has a fifty-two week low of $30.12 and a fifty-two week high of $38.28. The company has a market cap of $47.30 billion, a price-to-earnings ratio of 31.09, a PEG ratio of 2.54 and a beta of 0.45. The stock has a fifty day moving average price of $33.42 and a 200-day moving average price of $33.49.

Keurig Dr Pepper (NASDAQ:KDP) last announced its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%. The business had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. During the same period in the prior year, the company earned $0.45 EPS. Keurig Dr Pepper’s revenue for the quarter was up 6.1% on a year-over-year basis. As a group, equities analysts anticipate that Keurig Dr Pepper, Inc will post 1.92 EPS for the current fiscal year.

Keurig Dr Pepper Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were given a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, June 27th. Keurig Dr Pepper’s dividend payout ratio is currently 82.14%.

Wall Street Analyst Weigh In

KDP has been the topic of a number of research reports. Barclays upped their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Monday, July 28th. JPMorgan Chase & Co. decreased their price objective on Keurig Dr Pepper from $39.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, July 17th. HSBC raised Keurig Dr Pepper from a “hold” rating to a “buy” rating and upped their price objective for the company from $36.00 to $42.00 in a report on Friday, April 25th. Hsbc Global Res raised Keurig Dr Pepper from a “hold” rating to a “strong-buy” rating in a report on Friday, April 25th. Finally, Argus started coverage on Keurig Dr Pepper in a research report on Wednesday, April 16th. They set a “buy” rating and a $40.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $39.77.

Insider Buying and Selling

In related news, insider Mary Beth Denooyer sold 12,000 shares of the company’s stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the sale, the insider directly owned 82,511 shares in the company, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert James Gamgort sold 208,000 shares of the company’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the sale, the director owned 2,292,169 shares of the company’s stock, valued at approximately $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 672,000 shares of company stock worth $22,235,760 in the last ninety days. 0.40% of the stock is owned by insiders.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.